— Know what they know.
Not Investment Advice
Also trades as: ANTM (NYSE) · $vol 568M

ELV NYSE

Elevance Health Inc.
1W: -2.4% 1M: -4.4% 3M: -5.3% YTD: +9.1% 1Y: +16.8% 3Y: -10.0% 5Y: +7.5%
$386.43
+4.76 (+1.25%)
 
Weekly Expected Move ±3.7%
$358 $372 $386 $401 $415
NYSE · Healthcare · Medical - Healthcare Plans · Tech Score Sell · Power 47 · $83.8B mcap · 216M float · 0.642% daily turnover · Short 50% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.3 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 15.5%  ·  5Y Avg: 21.8%
Cost Advantage
45
Intangibles
55
Switching Cost
30
Network Effect
45
Scale ★
95
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ELV shows a Weak competitive edge (51.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 15.5% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$393
Low
$440
Avg Target
$488
High
Based on 9 analysts since Jul 15, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 27Hold: 11Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$447.54
Analysts13
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-07-17 Leerink Partners — $364 $395 +31 +7.0% $369.28
2026-07-16 Bernstein — $482 $488 +6 +30.9% $372.85
2026-07-16 New Street — Initiated $482 — +27.6% $377.63
2026-07-16 RBC Capital — $439 $424 -15 +8.6% $390.33
2026-07-16 Goldman Sachs — $343 $395 +52 +1.2% $390.33
2026-07-16 Robert W. Baird — $331 $393 +62 +0.7% $390.33
2026-07-16 Guggenheim — $399 $455 +56 +16.6% $390.33
2026-07-16 Wells Fargo Stephen Baxter $492 $473 -19 +21.2% $390.33
2026-07-16 Barclays — $480 $457 -23 +17.1% $390.33
2026-07-14 Truist Financial — $450 $475 +25 +11.7% $425.17
2026-07-13 Wells Fargo — $391 $492 +101 +18.2% $416.23
2026-07-09 RBC Capital Ben Hendrix $358 $439 +81 +3.1% $425.90
2026-07-07 Raymond James Sarah James $485 $450 -35 +10.2% $408.17
2026-07-02 Bernstein — $409 $482 +73 +15.8% $416.19
2026-06-08 Mizuho Securities — $435 $465 +30 +11.9% $415.53
2026-06-04 Morgan Stanley — $352 $404 +52 +3.3% $391.27
2026-06-01 Truist Financial David MacDonald $390 $450 +60 +14.4% $393.19
2026-05-26 Barclays Andrew Mok $408 $480 +72 +24.1% $386.87
2026-05-22 UBS — $400 $460 +60 +18.0% $389.82
2026-05-20 Mizuho Securities — $350 $435 +85 +8.1% $402.27
2026-05-20 Deutsche Bank — $332 $498 +166 +23.8% $402.27
2026-04-24 Guggenheim — $396 $399 +3 +15.2% $346.29
2026-04-24 Barclays — $393 $408 +15 +17.8% $346.29
2026-04-23 Leerink Partners — $515 $364 -151 +5.1% $346.21
2026-04-23 Robert W. Baird — $625 $331 -294 +0.9% $328.20
2026-04-20 Jefferies David Windley $529 $391 -138 +21.0% $323.05
2026-03-10 Mizuho Securities Ann Hynes $413 $350 -63 +23.8% $282.68
2026-02-03 RBC Capital — $478 $358 -120 +4.7% $341.83
2026-02-02 Truist Financial — $400 $390 -10 +14.3% $341.29
2026-02-02 Piper Sandler — Initiated $409 — +20.1% $340.68
2026-02-01 Bernstein — $431 $409 -22 +18.3% $345.74
2026-01-30 Wells Fargo — $424 $391 -33 +12.7% $346.98
2026-01-30 Barclays — $404 $393 -11 +13.3% $346.98
2026-01-29 UBS — $605 $400 -205 +15.9% $345.27
2026-01-29 Deutsche Bank — $320 $332 +12 -3.8% $345.22
2026-01-29 Guggenheim Jason Cassorla $414 $396 -18 +15.8% $341.85
2026-01-22 Guggenheim Jason Cassorla $398 $414 +16 +11.9% $369.88
2026-01-09 Mizuho Securities Ann Hynes $400 $413 +13 +10.2% $374.77
2026-01-08 Wolfe Research Justin Lake Initiated $425 — +15.9% $366.69
2026-01-07 Wells Fargo — $412 $424 +12 +14.2% $371.37
2026-01-06 Bernstein — $420 $431 +11 +17.0% $368.51
2026-01-05 Barclays Andrew Mok $385 $404 +19 +14.0% $354.25
2025-12-19 Deutsche Bank George Hill Initiated $320 — -7.1% $344.60
2025-12-18 Morgan Stanley — $359 $352 -7 +1.7% $345.96
2025-11-03 Mizuho Securities — $420 $400 -20 +27.7% $313.19
2025-10-22 Barclays — $395 $385 -10 +13.0% $340.76
2025-10-21 Bernstein — Initiated $420 — +20.5% $348.48
2025-10-14 Truist Financial — $500 $400 -100 +14.9% $348.16
2025-10-14 Morgan Stanley Erin Wright $643 $359 -284 +2.8% $349.16
2025-10-14 Goldman Sachs — Initiated $343 — -2.4% $351.42

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
5
ROE
4
ROA
5
D/E
1
P/E
3
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ELV receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-10-01 B+ A-
2026-08-28 A- B+
2026-08-24 B+ A-
2026-08-14 A- B+
2026-08-12 B+ A-
2026-07-25 A- B+
2026-07-16 B+ A-
2026-07-15 A- B+
2026-04-27 A A-
2026-04-22 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 57 Grade B
Profitability
38
Balance Sheet
76
Earnings Quality
84
Growth
39
Value
68
Momentum
69
Safety
80
Cash Flow
58
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ELV scores highest in Earnings Quality (84/100) and lowest in Profitability (38/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.13
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✓ ✗ ✓ ✗ ✓
Beneish M-Score
-2.71
Unlikely Manipulator
Ohlson O-Score
-8.43
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 74.0/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.50x
Accruals: -2.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ELV scores 3.13, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ELV scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ELV's score of -2.71 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ELV's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ELV receives an estimated rating of A (score: 74.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ELV's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
17.17x
PEG
-3.82x
P/S
0.42x
P/B
1.88x
P/FCF
13.40x
P/OCF
11.29x
EV/EBITDA
9.72x
EV/Revenue
0.39x
EV/EBIT
11.13x
EV/FCF
12.37x
Earnings Yield
5.89%
FCF Yield
7.46%
Shareholder Yield
5.00%
Graham Number
$324.90
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 17.2x earnings, ELV trades at a reasonable valuation. An earnings yield of 5.9% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $324.90 per share, 19% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.847
NI / EBT
×
Interest Burden
0.838
EBT / EBIT
×
EBIT Margin
0.035
EBIT / Rev
×
Asset Turnover
1.619
Rev / Assets
×
Equity Multiplier
2.803
Assets / Equity
=
ROE
11.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ELV's ROE of 11.2% is driven by Asset Turnover (1.619), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$193.60
Price/Value
2.00x
Margin of Safety
-99.76%
Premium
99.76%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ELV's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ELV trades at a 100% premium to its adjusted intrinsic value of $193.60, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 17.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$386.46
Median 1Y
$384.52
5th Pctile
$214.57
95th Pctile
$696.47
Ann. Volatility
33.8%
Analyst Target
$447.54
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Larry C. Glasscock
Chairman of the Board, President and Chief Executive Officer
$1,250,000 $3,168,000 $8,923,139
David C. Colby
Executive Vice President and Chief Financial Officer
$666,096 $1,029,600 $3,657,133
Keith R. Faller
President and CEO Central Region and Corporate Executive Vice President
$650,000 $1,029,600 $3,425,379
Joan E. Herman
President and CEO Specialty, Senior and State Sponsored Business and Corporate Executive Vice President
$573,022 $792,000 $2,699,912
John S. Watts,
Jr. President and CEO National Accounts Strategic Business Unit and Corporate Executive Vice President
$555,667 $792,000 $2,544,098

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
97,100
-6.8% YoY
Revenue / Employee
$2,050,721
Rev: $199,125,000,000
Profit / Employee
$58,311
NI: $5,662,000,000
SGA / Employee
—
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 15.8% 17.6% 17.8% 17.2% 17.2% 16.5% 16.8% 17.3% 16.3% 15.8% 16.0% 16.6% 15.6% 14.8% 14.2% 12.5% 12.6% 13.3% 12.1% 11.2% 11.20%
ROA 6.0% 6.6% 6.3% 6.2% 6.1% 6.0% 5.9% 6.1% 5.7% 5.7% 5.7% 6.0% 5.7% 5.3% 5.1% 4.6% 4.6% 4.8% 4.3% 4.0% 4.00%
ROIC 20.7% 21.8% 23.1% 22.2% 24.2% 22.1% 24.7% 25.4% 24.9% 21.2% 19.9% 19.4% 18.7% 15.3% 14.9% 13.4% 8.6% 9.3% 15.3% 15.5% 15.51%
ROCE 8.1% 9.0% 8.8% 8.6% 8.5% 8.3% 8.2% 8.5% 8.0% 8.0% 8.1% 8.5% 8.1% 7.8% 7.5% 6.9% 8.1% 8.0% 9.5% 7.5% 7.47%
Gross Margin 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 24.8% 23.5% 18.1% 89.1% 89.12%
Operating Margin 5.6% 3.8% 6.1% 5.5% 5.3% 2.9% 6.2% 5.6% 3.9% 2.3% 6.9% 6.8% 3.0% 1.3% 5.7% 4.6% 3.5% 1.2% 5.3% 4.1% 4.09%
Net Margin 4.2% 3.1% 4.7% 4.2% 4.0% 2.4% 4.7% 4.2% 3.0% 2.0% 5.3% 5.3% 2.3% 0.9% 4.5% 3.5% 2.3% 1.1% 3.5% 2.9% 2.90%
EBITDA Margin 7.1% 5.4% 7.5% 7.0% 7.0% 4.6% 7.9% 7.2% 5.5% 3.9% 8.3% 8.3% 4.4% 3.0% 7.2% 6.1% 4.2% 2.0% 5.5% 4.2% 4.17%
FCF Margin 7.1% 5.2% 5.0% 5.4% 6.8% 4.6% 6.9% 6.4% 4.9% 3.9% 1.3% 0.5% 0.5% 2.6% 2.0% 2.8% 1.9% 1.6% 3.2% 3.1% 3.13%
OCF Margin 7.8% 6.0% 5.8% 6.1% 7.6% 5.4% 7.7% 7.1% 5.6% 4.7% 2.1% 1.2% 1.2% 3.3% 2.6% 3.4% 2.5% 2.2% 3.8% 3.7% 3.71%
ROE 3Y Avg snapshot only 13.06%
ROE 5Y Avg snapshot only 14.57%
ROA 3Y Avg snapshot only 4.75%
ROIC 3Y Avg snapshot only 16.06%
ROIC Economic snapshot only 8.29%
Cash ROA snapshot only 5.90%
Cash ROIC snapshot only 19.43%
CROIC snapshot only 16.37%
NOPAT Margin snapshot only 2.96%
Pretax Margin snapshot only 2.91%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 3.15%
SBC / Revenue snapshot only 0.12%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 15.67 17.63 18.28 18.39 17.01 19.78 17.10 15.89 16.34 17.98 18.89 18.41 18.45 13.99 16.45 16.21 13.12 13.73 12.31 16.98 17.175
P/S Ratio 0.65 0.78 0.79 0.75 0.68 0.76 0.66 0.61 0.59 0.63 0.69 0.72 0.68 0.47 0.53 0.46 0.37 0.39 0.32 0.42 0.417
P/B Ratio 2.42 2.98 3.16 3.12 2.91 3.26 2.83 2.66 2.59 2.74 2.90 2.92 2.71 2.02 2.29 1.99 1.65 1.77 1.47 1.88 1.876
P/FCF 9.12 14.79 15.68 13.92 10.09 16.32 9.50 9.61 12.05 15.91 51.37 150.23 135.97 18.37 26.50 16.28 19.27 24.50 10.00 13.40 13.399
P/OCF 8.23 12.87 13.55 12.18 9.05 14.08 8.57 8.59 10.45 13.35 33.04 59.60 55.57 14.40 20.08 13.46 14.78 18.12 8.48 11.29 11.290
EV/EBITDA 8.46 9.93 10.23 10.21 9.12 10.65 8.72 7.98 8.02 9.21 10.16 10.35 10.05 7.76 9.03 8.43 9.58 10.51 6.82 9.72 9.716
EV/Revenue 0.58 0.72 0.73 0.69 0.62 0.70 0.58 0.54 0.51 0.56 0.63 0.67 0.62 0.46 0.52 0.44 0.49 0.51 0.30 0.39 0.387
EV/EBIT 9.77 11.41 11.82 11.94 10.74 12.74 10.46 9.55 9.64 11.05 11.97 11.98 11.57 8.95 10.46 9.92 11.32 12.51 7.97 11.13 11.127
EV/FCF 8.17 13.67 14.42 12.85 9.07 15.04 8.39 8.39 10.37 14.28 47.31 140.83 124.86 17.88 25.70 15.59 25.48 31.98 9.43 12.37 12.371
Earnings Yield 6.4% 5.7% 5.5% 5.4% 5.9% 5.1% 5.8% 6.3% 6.1% 5.6% 5.3% 5.4% 5.4% 7.2% 6.1% 6.2% 7.6% 7.3% 8.1% 5.9% 5.89%
FCF Yield 11.0% 6.8% 6.4% 7.2% 9.9% 6.1% 10.5% 10.4% 8.3% 6.3% 1.9% 0.7% 0.7% 5.4% 3.8% 6.1% 5.2% 4.1% 10.0% 7.5% 7.46%
Price/Tangible Book snapshot only 15.153
EV/OCF snapshot only 10.423
EV/Gross Profit snapshot only 0.993
Acquirers Multiple snapshot only 11.016
Shareholder Yield snapshot only 5.00%
Graham Number snapshot only $324.90
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio — — — — — — — — — — — — — — — — 1.29 1.24 1.48 2.05 2.050
Quick Ratio — — — — — — — — — — — — — — — — 1.29 1.24 1.48 2.05 2.050
Debt/Equity 0.64 0.64 0.65 0.66 0.66 0.67 0.68 0.66 0.65 0.64 0.65 0.66 0.62 0.76 0.71 0.69 0.73 0.76 0.73 0.69 0.692
Net Debt/Equity -0.25 -0.23 -0.25 -0.24 -0.30 -0.25 -0.33 -0.34 -0.36 -0.28 -0.23 -0.18 -0.22 -0.05 -0.07 -0.08 0.53 0.54 -0.08 -0.14 -0.144
Debt/Assets 0.23 0.24 0.23 0.23 0.23 0.23 0.23 0.23 0.22 0.23 0.24 0.25 0.23 0.27 0.25 0.25 0.26 0.27 0.25 0.25 0.246
Debt/EBITDA 2.49 2.30 2.27 2.34 2.30 2.36 2.38 2.26 2.33 2.39 2.47 2.48 2.51 2.98 2.87 3.06 3.21 3.44 3.57 3.88 3.877
Net Debt/EBITDA -0.99 -0.81 -0.89 -0.86 -1.03 -0.90 -1.15 -1.16 -1.30 -1.05 -0.87 -0.69 -0.89 -0.22 -0.28 -0.37 2.34 2.46 -0.42 -0.81 -0.808
Interest Coverage 10.04 10.93 10.98 10.66 10.68 10.06 9.90 9.74 8.87 8.49 8.70 9.07 8.52 7.67 7.14 6.33 6.16 5.79 5.39 6.19 6.188
Equity Multiplier 2.74 2.70 2.79 2.82 2.86 2.84 2.92 2.86 2.88 2.77 2.76 2.68 2.66 2.83 2.82 2.79 2.79 2.77 2.87 2.82 2.817
Cash Ratio snapshot only 1.144
Debt Service Coverage snapshot only 7.086
Cash to Debt snapshot only 1.208
FCF to Debt snapshot only 0.203
Defensive Interval snapshot only 311.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 1.45 1.51 1.47 1.51 1.52 1.56 1.53 1.58 1.58 1.62 1.55 1.55 1.53 1.57 1.58 1.61 1.63 1.67 1.63 1.62 1.619
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 15.14 25.30 16.55 14.88 15.39 24.54 13.76 18.38 18.29 22.87 16.39 22.20 23.06 22.22 18.99 20.45 17.82 17.13 18.32 18.75 18.747
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.97 3.83 7.78 4.96 4.958
DSO 24 14 22 25 24 15 27 20 20 16 22 16 16 16 19 18 20 21 20 19 19.5 days
DIO — — — — — — — — — — — — — — — — 0 0 0 0 0.0 days
DPO — — — — — — — — — — — — — — — — 185 95 47 74 73.6 days
Cash Conversion Cycle — — — — — — — — — — — — — — — — -165 -74 -27 -54 -54.2 days
Fixed Asset Turnover snapshot only 43.297
Cash Velocity snapshot only 5.361
Capital Intensity snapshot only 0.629
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 14.0% 13.8% 15.8% 15.4% 14.5% 13.0% 11.3% 11.1% 10.0% 9.4% 6.9% 3.6% 3.2% 3.2% 6.6% 10.2% 12.0% 12.6% 9.4% 6.3% 6.27%
Net Income 11.4% 33.5% 32.1% 43.5% 11.7% -2.1% -0.8% 5.3% -1.4% 0.2% 1.1% 4.6% 5.6% -0.1% -5.2% -19.9% -13.8% -5.3% -11.4% -7.4% -7.41%
EPS 15.1% 36.6% 34.2% 45.9% 13.5% -0.3% 1.1% 7.8% 1.0% 2.4% 3.4% 6.6% 7.1% 1.9% -2.3% -17.2% -11.0% -1.3% -8.7% -4.0% -4.05%
FCF 33.4% -24.7% -24.8% 38.8% 9.7% -0.4% 53.2% 31.8% -20.7% -6.7% -79.4% -92.2% -89.4% -32.7% 60.0% 5.5% 3.3% -30.3% 75.6% 17.8% 17.84%
EBITDA 6.3% 22.6% 23.8% 34.5% 12.9% 2.1% 4.5% 10.1% 3.1% 2.5% -0.1% 0.4% 1.5% -0.1% -2.2% -11.5% -7.5% -7.9% -14.8% -18.9% -18.90%
Op. Income 6.1% 27.0% 27.4% 41.5% 11.5% -2.7% -0.4% 6.6% -1.1% 0.1% 0.2% 2.9% 5.5% 2.4% -3.4% -17.6% -10.2% -6.0% -6.1% -0.1% -0.08%
OCF Growth snapshot only 15.65%
Asset Growth snapshot only 3.69%
Equity Growth snapshot only 2.66%
Debt Growth snapshot only 2.84%
Shares Change snapshot only -3.50%
Dividend Growth snapshot only 2.60%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 13.6% 14.6% 15.3% 15.5% 15.2% 14.5% 13.7% 13.6% 12.8% 12.0% 11.3% 9.9% 9.1% 8.4% 8.3% 8.3% 8.3% 8.3% 7.6% 6.7% 6.67%
Revenue 5Y 9.9% 10.3% 10.6% 11.1% 11.5% 11.7% 12.3% 12.8% 13.0% 13.2% 12.8% 12.2% 11.7% 11.2% 10.9% 10.9% 10.7% 10.3% 10.0% 9.3% 9.25%
EPS 3Y 9.3% 20.2% 18.8% 16.9% 15.5% 10.0% 11.4% 5.1% 9.7% 11.7% 12.0% 18.8% 7.1% 1.3% 0.7% -1.6% -1.3% 1.0% -2.6% -5.4% -5.38%
EPS 5Y 21.4% 22.0% 19.9% 18.8% 17.9% 11.2% 10.3% 10.4% 8.4% 12.2% 11.9% 12.9% 10.7% 6.8% 6.9% 0.5% 4.7% 7.0% 4.6% 5.9% 5.90%
Net Income 3Y 6.6% 17.6% 16.0% 14.2% 12.8% 7.5% 8.9% 2.6% 7.1% 9.4% 9.8% 16.5% 5.2% -0.7% -1.7% -4.1% -3.5% -1.8% -5.3% -8.1% -8.10%
Net Income 5Y 19.3% 19.8% 17.5% 16.3% 15.6% 9.2% 8.3% 8.0% 5.9% 9.8% 9.4% 10.4% 8.3% 4.5% 4.4% -2.0% 2.2% 4.4% 2.1% 3.2% 3.24%
EBITDA 3Y 12.4% 13.0% 12.8% 12.5% 12.0% 9.2% 10.2% 4.6% 7.4% 8.7% 8.9% 14.1% 5.7% 1.5% 0.7% -0.7% -1.1% -1.9% -5.9% -10.4% -10.35%
EBITDA 5Y 9.2% 10.1% 9.7% 10.3% 11.0% 12.8% 12.8% 12.3% 10.6% 8.6% 8.4% 9.5% 8.0% 5.9% 5.5% 0.4% 3.1% 3.4% 1.5% 1.3% 1.31%
Gross Profit 3Y 13.6% 14.6% 15.3% 15.5% 15.2% 14.5% 13.7% 13.6% 12.8% 12.0% 11.3% 9.9% 9.1% 8.4% 8.3% 8.3% 0.7% -7.8% -19.7% -22.1% -22.10%
Gross Profit 5Y 9.9% 10.3% 10.6% 11.1% 11.5% 11.7% 12.3% 12.8% 13.0% 13.2% 12.8% 12.2% 11.7% 11.2% 10.9% 10.9% 5.9% 0.2% -7.8% -9.5% -9.52%
Op. Income 3Y 15.3% 16.1% 15.5% 14.7% 13.6% 8.8% 9.4% 2.2% 5.4% 7.3% 8.3% 15.8% 5.2% -0.1% -1.2% -3.3% -2.2% -1.2% -3.1% -5.4% -5.40%
Op. Income 5Y 10.8% 11.7% 11.1% 11.6% 12.1% 14.2% 13.7% 13.0% 11.1% 8.8% 9.0% 10.6% 8.9% 5.7% 4.8% -2.0% 2.1% 3.6% 2.9% 5.0% 5.02%
FCF 3Y 1.2% 40.6% 53.2% 38.7% 35.8% 13.3% 23.6% 2.0% 5.1% -11.2% -38.0% -47.8% -54.9% -14.5% -20.3% -12.7% -28.7% -24.1% -16.6% -15.9% -15.89%
FCF 5Y 24.0% 22.7% 12.7% 16.8% 15.4% 16.4% 31.5% 30.1% 55.8% 20.9% 2.6% -22.9% -26.8% -1.8% -9.0% -11.7% -11.9% -20.0% -7.8% 1.7% 1.71%
OCF 3Y 72.0% 29.8% 37.3% 30.4% 30.6% 11.5% 21.1% 2.4% 5.1% -9.0% -30.6% -32.9% -41.2% -11.4% -16.7% -11.0% -24.9% -20.1% -14.9% -14.2% -14.22%
OCF 5Y 22.0% 21.2% 12.9% 16.2% 15.0% 15.0% 27.1% 25.1% 35.8% 16.1% 1.9% -13.0% -16.3% -0.8% -6.9% -10.1% -9.7% -16.7% -6.6% 1.7% 1.73%
Assets 3Y 9.6% 10.8% 10.5% 10.0% 9.8% 9.9% 9.8% 7.5% 8.5% 7.9% 5.4% 5.5% 5.9% 6.2% 6.0% 6.5% 6.0% 5.7% 4.9% 5.0% 5.02%
Assets 5Y 8.8% 8.4% 7.8% 8.1% 8.6% 7.8% 8.3% 8.0% 8.2% 8.8% 8.5% 8.3% 8.4% 8.6% 7.8% 6.7% 7.2% 7.0% 5.6% 5.6% 5.64%
Equity 3Y 7.1% 8.1% 6.2% 5.2% 4.7% 4.5% 5.6% 3.5% 4.2% 5.8% 6.3% 6.5% 7.0% 4.6% 5.7% 6.9% 6.9% 6.6% 5.5% 5.5% 5.52%
Book Value 3Y 9.8% 10.5% 8.8% 7.6% 7.2% 6.9% 8.0% 6.0% 6.8% 8.0% 8.3% 8.5% 8.9% 6.8% 8.3% 9.6% 9.4% 9.6% 8.5% 8.6% 8.64%
Dividend 3Y 7.6% 7.3% 7.2% 6.8% 6.5% 6.0% 6.2% 6.5% 6.7% 6.5% 5.9% 5.4% 4.9% 4.7% 4.6% 4.2% 3.4% 3.3% 2.9% 2.6% 2.62%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.90 0.90 0.91 0.92 0.94 0.96 0.98 0.98 0.99 1.00 0.99 0.98 0.98 0.98 0.99 0.98 0.98 0.98 0.99 0.98 0.984
Earnings Stability 0.90 0.88 0.87 0.60 0.90 0.85 0.85 0.54 0.88 0.80 0.85 0.60 0.92 0.60 0.56 0.09 0.30 0.22 0.02 0.01 0.011
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.91 0.81 0.70 0.69 0.689
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.50 0.50 0.50 1.00 0.00 0.00 1.00 0.00 0.50 0.50 1.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.95 0.87 0.87 0.83 0.95 0.99 1.00 0.98 0.99 1.00 1.00 0.98 0.98 1.00 0.98 0.92 0.94 0.98 0.95 0.97 0.970
Earnings Smoothness 0.89 0.71 0.72 0.64 0.89 0.98 0.99 0.95 0.99 1.00 0.99 0.95 0.95 1.00 0.95 0.78 0.85 0.95 0.88 0.92 0.923
ROE Trend 0.01 0.02 0.03 0.02 0.02 0.01 0.01 0.02 -0.00 -0.01 -0.02 -0.01 -0.02 -0.01 -0.02 -0.04 -0.03 -0.02 -0.03 -0.03 -0.030
Gross Margin Trend 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.20 -0.38 -0.59 -0.61 -0.610
FCF Margin Trend 0.02 -0.01 -0.02 -0.01 0.00 -0.02 0.01 0.01 -0.02 -0.01 -0.05 -0.05 -0.05 -0.02 -0.02 -0.01 -0.01 -0.02 0.02 0.01 0.015
Sustainable Growth Rate 12.8% 14.4% 14.6% 13.9% 13.9% 13.1% 13.4% 13.7% 12.7% 12.2% 12.4% 13.0% 12.0% 11.1% 10.6% 8.9% 9.1% 9.7% 8.6% 7.8% 7.80%
Internal Growth Rate 5.1% 5.7% 5.5% 5.2% 5.2% 5.0% 4.9% 5.1% 4.6% 4.5% 4.6% 5.0% 4.5% 4.1% 4.0% 3.4% 3.5% 3.6% 3.1% 2.9% 2.86%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.90 1.37 1.35 1.51 1.88 1.40 2.00 1.85 1.56 1.35 0.57 0.31 0.33 0.97 0.82 1.20 0.89 0.76 1.45 1.50 1.504
FCF/OCF 0.90 0.87 0.86 0.87 0.90 0.86 0.90 0.89 0.87 0.84 0.64 0.40 0.41 0.78 0.76 0.83 0.77 0.74 0.85 0.84 0.843
FCF/Net Income snapshot only 1.267
OCF/EBITDA snapshot only 0.932
CapEx/Revenue 0.8% 0.8% 0.8% 0.8% 0.8% 0.7% 0.7% 0.8% 0.8% 0.8% 0.7% 0.7% 0.7% 0.7% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.58%
CapEx/Depreciation snapshot only 1.158
Accruals Ratio -0.05 -0.02 -0.02 -0.03 -0.05 -0.02 -0.06 -0.05 -0.03 -0.02 0.02 0.04 0.04 0.00 0.01 -0.01 0.01 0.01 -0.02 -0.02 -0.020
Sloan Accruals snapshot only 0.269
Cash Flow Adequacy snapshot only 2.783
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 1.2% 1.0% 1.0% 1.0% 1.1% 1.0% 1.2% 1.3% 1.4% 1.3% 1.2% 1.2% 1.3% 1.8% 1.6% 1.8% 2.1% 2.0% 2.4% 1.8% 1.78%
Dividend/Share $4.33 $4.50 $4.65 $4.79 $4.94 $5.10 $5.30 $5.52 $5.73 $5.92 $6.08 $6.22 $6.35 $6.53 $6.67 $6.74 $6.75 $6.89 $6.89 $6.92 $6.87
Payout Ratio 19.3% 18.1% 18.2% 19.2% 19.4% 20.6% 20.6% 20.5% 22.3% 23.3% 22.8% 21.7% 23.1% 25.2% 25.6% 28.4% 27.6% 27.0% 29.0% 30.4% 30.36%
FCF Payout Ratio 11.2% 15.2% 15.6% 14.5% 11.5% 17.0% 11.4% 12.4% 16.4% 20.6% 62.0% 1.8% 1.7% 33.1% 41.2% 28.5% 40.5% 48.2% 23.6% 24.0% 23.96%
Total Payout Ratio 68.9% 49.2% 50.3% 54.5% 56.2% 59.3% 59.3% 58.3% 60.4% 68.0% 64.8% 58.1% 54.5% 73.7% 79.9% 86.8% 98.9% 73.0% 83.3% 84.9% 84.87%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0
Chowder Number 0.17 0.17 0.16 0.15 0.14 0.12 0.13 0.14 0.14 0.15 0.13 0.12 0.11 0.10 0.08 0.07 0.05 0.03 0.03 0.01 0.008
Buyback Yield 3.2% 1.8% 1.8% 1.9% 2.2% 2.0% 2.3% 2.4% 2.3% 2.5% 2.2% 2.0% 1.7% 3.5% 3.3% 3.6% 5.4% 3.4% 4.4% 3.2% 3.21%
Net Buyback Yield 3.2% 1.8% 1.8% 1.9% 2.2% 2.0% 2.3% 2.4% 2.3% 2.5% 2.2% 2.0% 1.7% 3.5% 3.3% 3.6% 5.4% 3.3% 4.3% 3.1% 3.14%
Total Shareholder Return 4.4% 2.8% 2.8% 3.0% 3.3% 3.0% 3.5% 3.7% 3.7% 3.8% 3.4% 3.2% 3.0% 5.3% 4.9% 5.4% 7.5% 5.2% 6.6% 4.9% 4.93%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.77 0.77 0.77 0.78 0.78 0.78 0.77 0.77 0.77 0.78 0.78 0.78 0.77 0.76 0.76 0.76 0.78 0.84 0.84 0.85 0.847
Interest Burden (EBT/EBIT) 0.90 0.91 0.91 0.91 0.91 0.90 0.90 0.90 0.89 0.88 0.89 0.89 0.88 0.87 0.86 0.84 0.84 0.83 0.81 0.84 0.838
EBIT Margin 0.06 0.06 0.06 0.06 0.06 0.05 0.06 0.06 0.05 0.05 0.05 0.06 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.03 0.035
Asset Turnover 1.45 1.51 1.47 1.51 1.52 1.56 1.53 1.58 1.58 1.62 1.55 1.55 1.53 1.57 1.58 1.61 1.63 1.67 1.63 1.62 1.619
Equity Multiplier 2.65 2.66 2.81 2.78 2.80 2.77 2.86 2.84 2.87 2.80 2.83 2.76 2.76 2.80 2.79 2.73 2.73 2.80 2.84 2.80 2.803
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $22.43 $24.86 $25.48 $24.95 $25.46 $24.78 $25.77 $26.89 $25.71 $25.39 $26.66 $28.67 $27.53 $25.88 $26.04 $23.74 $24.50 $25.53 $23.79 $22.78 $22.78
Book Value/Share $145.27 $146.88 $147.20 $147.13 $148.60 $150.26 $155.84 $160.66 $162.47 $166.69 $173.39 $180.77 $187.79 $178.78 $187.07 $193.63 $194.65 $197.84 $199.19 $205.98 $206.62
Tangible Book/Share $3.27 $4.96 $4.65 $2.81 $4.43 $6.41 $4.87 $9.37 $11.17 $15.76 $16.87 $24.77 $32.10 $4.08 $9.43 $17.11 $18.49 $19.56 $20.28 $25.52 $25.52
Revenue/Share $544.24 $564.72 $590.63 $612.70 $632.73 $649.23 $670.30 $696.85 $712.99 $726.63 $733.33 $735.73 $746.53 $765.08 $806.00 $838.15 $862.80 $897.77 $909.32 $922.96 $922.96
FCF/Share $38.54 $29.64 $29.72 $32.96 $42.92 $30.05 $46.42 $44.45 $34.87 $28.69 $9.80 $3.51 $3.74 $19.70 $16.17 $23.64 $16.68 $14.31 $29.26 $28.86 $28.86
OCF/Share $42.70 $34.07 $34.37 $37.67 $47.85 $34.82 $51.43 $49.73 $40.23 $34.19 $15.24 $8.86 $9.14 $25.13 $21.33 $28.58 $21.75 $19.34 $34.51 $34.25 $34.25
Cash/Share $129.42 $126.87 $132.49 $132.38 $142.02 $138.22 $157.61 $159.85 $163.76 $153.27 $152.67 $151.66 $157.96 $144.91 $144.97 $149.95 $38.59 $42.79 $161.35 $172.16 $172.16
EBITDA/Share $37.22 $40.84 $41.90 $41.48 $42.69 $42.43 $44.65 $46.74 $45.08 $44.49 $45.66 $47.81 $46.43 $45.36 $46.04 $43.72 $44.35 $43.54 $40.46 $36.75 $36.75
Debt/Share $92.62 $93.81 $95.15 $96.91 $98.15 $99.98 $106.24 $105.65 $105.05 $106.53 $112.94 $118.62 $116.47 $135.14 $132.06 $133.68 $142.17 $149.84 $144.47 $142.47 $142.47
Net Debt/Share $-36.80 $-33.06 $-37.34 $-35.47 $-43.87 $-38.25 $-51.36 $-54.20 $-58.71 $-46.73 $-39.73 $-33.04 $-41.49 $-9.77 $-12.91 $-16.26 $103.58 $107.05 $-16.88 $-29.69 $-29.69
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.127
Altman Z-Prime snapshot only 4.189
Piotroski F-Score 7 6 7 7 7 6 5 7 6 6 4 5 5 3 4 5 4 4 5 6 6
Beneish M-Score -2.52 -2.33 -2.39 -2.50 -2.62 -2.40 -2.60 -2.54 -2.26 -2.28 -2.10 -1.95 -2.21 -2.39 -2.23 -2.32 -1.08 -0.95 -0.37 -2.71 -2.709
Ohlson O-Score snapshot only -8.434
ROIC (Greenblatt) snapshot only 17.91%
Net-Net WC snapshot only $-65.31
EVA snapshot only $2118391914.02
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 73.84 79.26 79.27 78.55 78.09 77.62 76.39 75.34 75.72 72.54 72.60 68.73 69.75 66.83 64.96 60.82 64.94 62.75 67.87 73.99 73.994
Credit Grade snapshot only 6
Credit Trend snapshot only 13.172
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 73
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms